Gait analyzer market seen reaching $2.33 billion by 2030

The gait analyzer market is projected to rise from $1.56 billion in 2026 to $2.33 billion by 2030, driven by more musculoskeletal disorders, aging populations and wider use in rehabilitation, sports medicine and clinical mobility assessment. North America held the largest share in 2025 and is expected to keep the lead through 2026.

Why it matters: - Gait analyzers are moving from a niche clinical tool to a broader mobility assessment technology. - Demand is tied to rising musculoskeletal and bone-related disorders, which can increase the need for diagnosis, monitoring and treatment planning. - Growth also reflects expanding use in rehabilitation, sports medicine and home-based care.

What happened: - The gait analyzer market grew from $1.41 billion in 2025 to an expected $1.56 billion in 2026. - The market is forecast to reach $2.33 billion by 2030. - The report pegs the market’s CAGR at 10.6% through 2030. - North America held the largest market share in 2025. - North America is expected to remain the leading region through 2026. - The report covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - Download a free sample of the report. - View the full gait analyzer market report.

The details: - Gait analyzers evaluate human walking patterns to detect abnormalities and support mobility improvements. - The systems help diagnose, monitor and manage movement- and posture-related conditions. - Healthcare uses include clinical diagnosis and treatment. - Sports uses include performance optimization. - Academic research uses include studying human movement. - Growth drivers include more rehabilitation and physiotherapy centers, stronger awareness of mobility assessments in clinical settings and wider use in sports medicine. - Forecast drivers include an aging population, preventive health efforts, early diagnosis, home-based rehabilitation, personalized treatment planning and sports and fitness monitoring. - Expected product trends include wearable gait analysis tools, portable devices and home-use analyzers. - The report also points to rising demand for objective tools to evaluate mobility and posture.

Between the lines: - The market outlook suggests gait analysis is becoming more practical outside hospital settings, especially as wearable and portable systems gain traction. - The report links future demand to a shift toward earlier intervention and more personalized care, not just post-injury recovery. - Bone-related surgery volumes add another layer of demand because gait analysis can support surgical preparation and recovery tracking. - Research cited in the report projects total hip arthroplasty procedures will reach 719,364 by 2040 and total knee arthroplasty procedures will reach 1.22 million by 2040. - The same research projects total knee arthroplasties will reach 2.91 million by 2060 and total hip arthroplasties will reach 1.98 million by 2060.

What's next: - The market is expected to keep expanding at a 10.6% annual pace through 2030. - Wider adoption of wearable gait analysis technologies is likely to shape product development. - More use in rehabilitation, physiotherapy, sports performance tracking and home care is expected. - The report says its 2026 editions add market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.